Publications by authors named "Gil Golden"

Claim this Profile
G
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey by the PVRI IDDI Access to Care Workstream.
Sasha Z Prisco, Alexander Kantorovich, Yan Liu, Sandeep Sahay, Roberto Bernardo, Gil Golden

Pulm Circ· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Carmine Dario Vizza, Irene M Lang, Roberto Badagliacca, Raymond L Benza, Stephan Rosenkranz, Gil Golden

Am J Respir Crit Care Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer.
Martin J Edelman, Mikhail Dvorkin, Konstatin Laktionov, Alejandro Navarro, Oscar Juan-Vidal, Gil Golden

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension.
Aaron Waxman, Shih-Yin Chen, Luke Boulanger, Jay A Watson, Gil Golden

J Med Econ· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Anthony R Disanto, Gil Golden

Clin Drug Investig· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia.
Gil Golden, Gilbert Honigfeld

Clin Drug Investig· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical education and communication companies: an updated in-depth profile.
Gil A Golden, Jacqueline N Parochka, Karen M Overstreet

J Contin Educ Health Prof· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis